草业学报
草業學報
초업학보
PRATACULTURAL SCIENCE
2014年
4期
138-145
,共8页
张伟伟%袁蓓%张占路%赵杨敏%徐秉良%吴燕民
張偉偉%袁蓓%張佔路%趙楊敏%徐秉良%吳燕民
장위위%원배%장점로%조양민%서병량%오연민
百脉根%载体构建%H A抗原蛋白%LTB免疫佐剂%高表达
百脈根%載體構建%H A抗原蛋白%LTB免疫佐劑%高錶達
백맥근%재체구건%H A항원단백%LTB면역좌제%고표체
Lotus corniculatus%vector construction%hemagglutinin (HA)%LTB%a high expression level
为提高外源抗原蛋白的表达水平,根据已得到的 HA-LTB融合基因,通过添加双增强子CaMV35S启动子、增强子Ω序列、内质网滞留信号KDEL序列及加长poly(A)序列等表达调控元件,构建 HA-LTB高效融合植物表达载体。利用农杆菌介导方法转化百脉根,获得转基因阳性植株21株,经PCR 和RT-PCR 检测表明 HA-LTB融合基因已整合到百脉根基因组中。利用ELISA检测转基因植株,结果表明LTB免疫佐剂与 HA抗原蛋白均具有免疫原性,LTB最高表达量达到0.086μg/mg(蛋白粗提液),HA最高表达量达到0.25μg/mg(蛋白粗提液)。通过植物表达载体的设计和构建,使禽流感血凝素在百脉根中的表达量得到了显著提高,为禽流感可饲疫苗的研制奠定了基础。
為提高外源抗原蛋白的錶達水平,根據已得到的 HA-LTB融閤基因,通過添加雙增彊子CaMV35S啟動子、增彊子Ω序列、內質網滯留信號KDEL序列及加長poly(A)序列等錶達調控元件,構建 HA-LTB高效融閤植物錶達載體。利用農桿菌介導方法轉化百脈根,穫得轉基因暘性植株21株,經PCR 和RT-PCR 檢測錶明 HA-LTB融閤基因已整閤到百脈根基因組中。利用ELISA檢測轉基因植株,結果錶明LTB免疫佐劑與 HA抗原蛋白均具有免疫原性,LTB最高錶達量達到0.086μg/mg(蛋白粗提液),HA最高錶達量達到0.25μg/mg(蛋白粗提液)。通過植物錶達載體的設計和構建,使禽流感血凝素在百脈根中的錶達量得到瞭顯著提高,為禽流感可飼疫苗的研製奠定瞭基礎。
위제고외원항원단백적표체수평,근거이득도적 HA-LTB융합기인,통과첨가쌍증강자CaMV35S계동자、증강자Ω서렬、내질망체류신호KDEL서렬급가장poly(A)서렬등표체조공원건,구건 HA-LTB고효융합식물표체재체。이용농간균개도방법전화백맥근,획득전기인양성식주21주,경PCR 화RT-PCR 검측표명 HA-LTB융합기인이정합도백맥근기인조중。이용ELISA검측전기인식주,결과표명LTB면역좌제여 HA항원단백균구유면역원성,LTB최고표체량체도0.086μg/mg(단백조제액),HA최고표체량체도0.25μg/mg(단백조제액)。통과식물표체재체적설계화구건,사금류감혈응소재백맥근중적표체량득도료현저제고,위금류감가사역묘적연제전정료기출。
A safe and efficient plant expression vector,HA-LTB,which added double 35S promoter,Ωenhan-cer,endoplasmic reticulum retention signal KDEL sequence and extended poly (A)sequence was constructed. Twenty one transgenic Lotus corniculatus plants were obtained by the Agrobacterium-mediated method and the results of PCR and RT-PCR showed that the HA-LTB gene had been obtained from the plant genome. ELISA results of the B subunit of Escherichiacoli heat-labile enterotoxin (LTB)showed that LTB could be ex-pressed in transgenic L. corniculatus and had immunogenicity.It was concluded that hemagglutinin (HA ) which was fused with LTB had immune activity.The highest expressions of LTB and HA were 0.086μg/mg (crude protein extracts)and 0.25μg/mg (crude protein extracts)respectively which has approached advanced international standards.A high level exogenous antigen protein expression platform which was a basis for re-search on the H5N1 avian influenza vaccine was established by optimizing the expression vector.